Myject S 360mg Tablet DR
By Myject S
Rx
10 Tablet DR in a Strip

Composition
Mycophenolate sodium(360mg)

Manufacturer - Septalyst Lifesciences Pvt.Ltd.
P-109, Jai Mata Di Complex, Opp Ranbaxy Laboratories,Kalhar Bhiwandi , Thane Maharashtra -421 302

Expires on or after
July, 2025

liver
Myject S 360mg Tablet DR is considered safe for individuals with liver disease, based on the limited available data. It appears that adjusting the dosage of Myject S 360mg Tablet DR may not be necessary for patients with liver issues. However, it is always advisable to seek guidance from your doctor before using this medication, especially if you have any concerns regarding your liver health.

kidney
Myject S 360mg Tablet DR requires caution in severe kidney disease. Adjusting the dose may be necessary. Consult your doctor for guidance.

alcohol
When taking Myject S 360mg Tablet DR, it is safe to consume alcohol as there are no harmful side effects reported. For further information on alcohol consumption with this medication, consult your doctor.

driving
Myject S 360mg Tablet DR generally does not impact driving ability.

pregnancy
Myject S 360mg Tablet DR is not safe during pregnancy due to potential risk to the baby. Consult your doctor before use.

breastfeeding
Caution is advised while breastfeeding and using Myject S 360mg Tablet DR as it is considered unsafe. There is a risk that this medication may harm the baby.
Habit Forming | No |
Chemical Class | Phthalide Derivative |
Therapeutic Class | - |
Action Class | Immunosuppressant- Purine analogs |
₹879
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024